Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-27

FDA Approved: ZOMIG — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal's original application for zolmitriptan (generic) for the acute treatment of migraine, expanding access to a generic form of ZOMIG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOMIG (ZOLMITRIPTAN)